INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 48 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $37,346,000 | +128679.3% | 31,920 | -0.6% | 0.01% | +20.0% |
| Q2 2020 | $29,000 | +7.4% | 32,120 | 0.0% | 0.01% | -16.7% |
| Q1 2020 | $27,000 | -99.9% | 32,120 | +4.6% | 0.01% | +20.0% |
| Q4 2019 | $29,467,000 | +81752.8% | 30,695 | -12.6% | 0.01% | -28.6% |
| Q3 2019 | $36,000 | -70.2% | 35,120 | -47.9% | 0.01% | -70.8% |
| Q2 2019 | $121,000 | -11.0% | 67,380 | -6.9% | 0.02% | -14.3% |
| Q1 2019 | $136,000 | +54.5% | 72,380 | -3.3% | 0.03% | +40.0% |
| Q4 2018 | $88,000 | -56.0% | 74,880 | -23.3% | 0.02% | -50.0% |
| Q3 2018 | $200,000 | +9.3% | 97,630 | +2.1% | 0.04% | +17.6% |
| Q2 2018 | $183,000 | +2.8% | 95,630 | +13.0% | 0.03% | -2.9% |
| Q1 2018 | $178,000 | -42.9% | 84,630 | -45.0% | 0.04% | -40.7% |
| Q4 2017 | $312,000 | – | 153,800 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,866,108 | $25,408,000 | 4.32% |
| Nine Chapters Capital Management LLC | 91,500 | $296,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,969,225 | $6,361,000 | 0.24% |
| Orbimed Advisors | 3,250,300 | $10,498,000 | 0.12% |
| PINNACLE ASSOCIATES LTD | 1,306,679 | $4,221,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 810,232 | $2,617,000 | 0.07% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 270,417 | $873,000 | 0.06% |
| Rock Springs Capital Management LP | 270,000 | $872,000 | 0.05% |
| ALGERT GLOBAL LLC | 39,876 | $129,000 | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 391,671 | $1,265,000 | 0.03% |